default author photo

Maribel González-Acosta

Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology

P.O. Box 2046

Barcelona, E-08907

Spain

  • Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology

SCHOLARLY PAPERS

1

DOWNLOADS

32

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Implementing a Molecular Prescreening Strategy for Tumors Without Public NGS Access in a Cancer Center Network: Results from the PREICO Project

Number of pages: 29 Posted: 30 Jan 2026
Paula Sàbat, Maria Ajenjo-Bauza, Cinta Hierro, Jose C. Ruffinelli, Marta Gil-Martin, María Ochoa-de-Olza, Milana A. Bergamino Sirvén, Mariona Calvo, Juan José Soto-Castillo, Clàudia Fina, Sandra Llop, Agostina Stradella, Marc Oliva, Lucía Notario, Enric Carcereny, EDUARD TEIXIDOR, Marta Domènech, Maria Jové, Rafael Villanueva, Ania Alay, Daniel Azuara, Maribel González-Acosta, Sara Otero-Torres, Mireia Gausachs, Mar Varela, Sergi Villatoro, Ares Solanes, Alexandre Teulé, Carmen Cuadra, Victor Rau Moreno, Ernest Nadal, David Cordero, Conxi Lázaro and Juan Martin-Liberal
affiliation not provided to SSRN, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Institut Català d'Oncologia, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol - Medical Oncology Department, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospitalet del Llobregat - Biomarkers and Susceptibility Unit (UBS), Bellvitge University Hospital, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology and Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology
Downloads 32 (1,290,922)

Abstract:

Loading...

Precision medicine, Precision Oncology, Genomic alterations, Next-Generation Sequencing, NGS access, Public Cancer Centre Network